On-Site Medical & Biological Waste Treatment Technologies

Innovative and low-emission solutions developed for the on-site treatment of medical, biological, and pathological waste.

EnviraMed, through the EnviraClean product family developed using Tekgen’s R&D infrastructure, offers a waste management approach that simplifies operations, reduces reliance on external services, and enables greater process control.

Conventional medical waste management is largely based on transportation and off-site disposal. Beyond disposal fees, this approach increases logistical complexity, environmental impact, and operational risk.

For this reason, healthcare institutions are increasingly turning to on-site, low-emission, and controlled solutions.

Why Change?

Hidden Costs of Conventional Approaches

High Logistics & Disposal Costs

Transportation, temporary storage, and outsourced disposal services increase operational costs over the long term.

Environmental Impact & Regulatory Expectations

Incineration- and landfill-based methods face increasing challenges in meeting sustainability goals and evolving regulatory requirements.

Biosafety & Infection Risks

Transporting and storing untreated waste exposes personnel to avoidable biosafety risks.

The EnviraClean Product Family

EnviraMed offers a product family designed to process medical, biological, and pathological waste at the source, in a controlled and low-emission manner.

This approach aims to reduce dependency on external services, simplify operations, and establish a safer waste management workflow.

EnviraClean Patho

EnviraClean Patho provides a non-incineration disposal approach based on alkaline hydrolysis for the treatment of pathological waste and animal by-products.

The system targets the chemical breakdown of organic tissues under controlled conditions, achieving high levels of biological inactivation with an emission-free process flow.

Combined with ozone-assisted auxiliary processes, it enables the safe, on-site treatment of tissues and biological materials.

EnviraClean Solid

EnviraClean Solid systems utilize the strong oxidative effect of ozone for the disinfection of contaminated solid medical waste.

The integrated shredding structure aims to reduce microbial risk, decrease waste volume, and minimize the need for chemical disinfectants.

This enables safer management of solid medical waste while reducing logistical burden.

EnviraClean Liquid

EnviraClean Liquid combines ozone-based oxidation and UV-assisted disinfection approaches for liquid medical waste and laboratory effluents.

This two-stage structure creates a controlled disinfection process for liquids with high microbial loads, supporting safe discharge requirements under appropriate conditions.

EnviraClean Patho offers a non-incineration disposal approach based on alkaline hydrolysis for the treatment of pathological waste and animal by-products.

This approach aims to enable the controlled breakdown of organic tissues, achieve high-level biological inactivation, and operate without combustion or the generation of harmful emissions.

By combining the alkaline hydrolysis process with ozone-assisted auxiliary treatments, tissues, organs, and biological materials can be processed safely at the point of generation, in a regulation-compliant and environmentally responsible manner.

EnviraClean Patho – A Dedicated Solution for Pathological Waste and Animal By-Products

Who is it suitable for?
  • Municipalities and animal services units

  • Veterinary faculties and clinics

  • Pathology and research laboratories

  • Slaughterhouses and animal by-product producers

Why is it preferred?
  • Reduction of reliance on external disposal services through on-site treatment

  • Minimization of biosafety risks associated with transport and transfer

  • A more controlled and predictable operational workflow

What can you contact us for?

  • Information about all brands, products and technology platforms developed within Tekgen

  • Systems under productization, including technical approaches and development roadmaps

  • R&D, research and technology-driven collaboration opportunities

  • Corporate, strategic and commercial partnerships

  • General corporate inquiries

Submit a Request